ClinicalTrials.gov
public full text
Public Domain
A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
This is a regulatory-required non-interventional pharmacovigilance study exploring the safety profile of ziprasidone HCL monohydrate 20mg, 40mg, 60mg, 80mg in the real world patient population, thus, safety (and/or efficacy) signals will be checked at every visit during the contracted study period until the maximum study end date, per the protocol, of April 2010.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sequential analysis for post-marketing drug safety surveillance using routinely collected electronic healthcare data: a scoping review.#354638
- Poland – Medical equipments, pharmaceuticals and personal care products – Dostawa implantów neurochirurgicznych, materiałów szewnych, rękawic medycznych, materiałów opatrunkowych i innych wyrobów medy — Szpitale Zachodniopomorskie Samodziel#1098843
- Korean Post-marketing Surveillance for Xeljanz XR#979928
- Electronic Pharmacotherapy Risk Management#840775
- Infringement by Drug Label#333968
Record · ID 884429
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive